Clinical Trial Update: Peptide-specific Vaccination in HLA-A*02 Positive Patients With Biochemical Recurrence After Radical Prostatectomy [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial is evaluating a peptide-specific vaccination in HLA-A*02 positive patients with biochemical recurrence after radical prostatect…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Recurrent Prostate Cancer | Phase 1, Phase 2 | Status: UNKNOWN